AssayProven™
A curated portfolio designed for assay development
Start stronger. Develop faster. Build with greater assay confidence.
Assay development often starts with uncertainty. Teams can spend valuable time screening reagent
combinations, troubleshooting unexpected performance issues, and generating characterization data before moving forward.
AssayProven™ helps change that starting point. Every AssayProven™ reagent pair is selected through an extensive screening and evaluation process to identify the highest-performing combinations before they become part of the AssayProven portfolio.
As a curated portfolio of matched assay components, development-ready performance data, and format-relevant validation, AssayProven™ helps reduce technical risk, simplify reagent selection, and support a faster path from evaluation to assay optimization.
AssayProven™ components are evaluated in relevant assay formats – including CLIA, FIA, and LFA – helping reduce uncertainty during assay design, optimization, and transfer.
Supported by characterization data
Sensitivity, specificity, cross-reactivity, affinity, and performance data help developers make more confident decisions before extensive internal testing begins.
Built for assay development
Coordinated antibody pairs, analytes, controls, and supporting documentation help simplify reagent selection and reduce compatibility risk.
Less time evaluating. More time optimizing.
Traditional catalog reagents are often selected individually, leaving development teams to determine compatibility, performance, and assay fit on their own.
AssayProven™ helps teams move forward with:
- Matched assay components
- Known assay performance
- Cross-reactivity and specificity data
- Platform-specific validation
- Supporting technical documentation
Built on Meridian Life Science’s quality foundation
AssayProven™ combines development-ready reagents with Meridian Life Science’s manufacturing, quality, and technical foundation — giving developers greater confidence from reagent selection through commercialization.